Mucoepidermoid carcinoma of the lung, response to EGFR inhibitors, EGFR and K-RAS mutations, and differential diagnosis

Giulio Rossi, Giuliana Sartori, Alberto Cavazza, Stefano Tamberi

Research output: Contribution to journalArticlepeer-review

Abstract

Mucoepidermoid carcinoma (MEC) of the lung needs to be carefully distinguished from other lung tumors with similar features, particularly from adenosquamous carcinoma, this latter tumor frequently showing EGFR mutations. In contrast with the data reported by Han et al in the last July issue of Lung Cancer, neither EGFR nor K-RAS mutations were observed in MEC from caucasian patients.

Original languageEnglish
Pages (from-to)159-160
Number of pages2
JournalLung Cancer
Volume63
Issue number1
DOIs
Publication statusPublished - Jan 2009

Keywords

  • EGFR
  • K-RAS
  • Lung
  • MUC5AC
  • Mucoepidermoid carcinoma

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Fingerprint Dive into the research topics of 'Mucoepidermoid carcinoma of the lung, response to EGFR inhibitors, EGFR and K-RAS mutations, and differential diagnosis'. Together they form a unique fingerprint.

Cite this